CAU
LLY icon

Caxton Associates (UK)’s Eli Lilly LLY Stock Holding History

Caxton Associates (UK)’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,526
Closed -$1.4M – 876
2026
Q1 		$1.4M Buy
1,526
+1,120
+276% +$1.14M 0.03% 300
2025
Q4 		$436K Sell
406
-894
-69% -$855K 0.01% 536
2025
Q3 		$992K Buy
+1,300
New +$967K 0.02% 341
2025
Q2 		– Sell
-2,570
Closed -$2.12M – 808
2025
Q1 		$2.12M Buy
+2,570
New +$2.14M 0.07% 145

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Caxton Associates (UK)'s LLY Position: Q2 2026 in Review

Caxton Associates (UK) sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 1,526 shares — an estimated $1.4M sold.

Caxton Associates (UK) first reported a position in LLY in Q1 2025 and held it in 4 quarters. The position peaked at $2.12M in Q1 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Caxton Associates (UK) reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 1,526 Eli Lilly shares in Q2 2026, an estimated $1.4M.
  • Caxton Associates (UK) first reported a position in Eli Lilly in Q1 2025 and held it in 4 quarters.
  • Caxton Associates (UK)'s Eli Lilly position peaked at $2.12M in Q1 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.